Aggregation of commercial heparin samples in storage.
The size distribution of heparin aggregates in commercial heparin preparations was examined with the technique of quasi-elastic light scattering. The size distributions were initially examined to determine if any relationship existed between the physical state of the heparin preparation, its age, and its biological activity. It was found that commercial heparin samples change their aggregation state in storage. The amount of aggregation appears to be related to the amount of time in storage and to the storage history. Storage of the samples under conditions of refrigeration and handling represents the storage history that most noticeably increases the aggregation state of the heparin preparations. These aggregates, once formed, appear to be stable. The biological activity of the heparin samples (as measured by the official test) was found to still fall within the accepted limits, independent of the aggregation state of the samples. It is not known what effect, if any, a change in the physical state of the commercial preparation should have on its biological activity.
D004355:Drug Stability; D004356:Drug Storage; D006493:Heparin / Q000032:analysis* / Q000494:pharmacology; D008027:Light; D010316:Particle Size; D012542:Scattering, Radiation
D006493:Heparin